The Trevo Retriever is intended to restore blood fl ow in the neurovasculature by removing thrombus in patients experiencing ischemic stroke within 8 hours of symptom onset. Patients who are ineligible for intravenous tissue plasminogen activator (IV t-PA) or who fail IV t-PA therapy are candidates for treatment.
Background
Ischemic stroke in young and middle-aged adults has various etiologies. Carotid web is an underestimated cause of recurrent ischemic stroke and has been described by multiple case reports. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] It was first described as a stigma of fibromuscular hyperplasia in 1965 1 followed by similar reports in 1967 and 1968. 2, 3 Since then it has been described in the literature using other synonyms such as atypical fibromuscular dysplasia, 4, 5 atypical fibromuscular hyperplasia, 6, 7 septal fibromuscular dysplasia, 8, 9 septa, 4,10,11 diaphragms, 12, 13 pseudo-valvular folds 14 and webs. 10, 15, 16, 17 In most of the reported cases, the diagnosis of carotid web was based on conventional digital subtraction angiography (DSA) appearance as a translucent linear endoluminal filling defect.
Lenck et al. first reported endovascular stenting as an option for stroke secondary prevention in patients with carotid webs 13 while the prior literature suggested management options such as surgical resection 1-3,5-9,11,12,14-16 and/or medical treatment including anticoagulation 11, 13 and antiplatelet therapy. 5 
Case presentation
Both cases were admitted to our institution in the last two years with history of recurrent stroke confined to a single arterial territory. Both patients had initiated antiplatelet therapy following the initial ischemic event. Ischemic strokes were confirmed by magnetic resonance imaging (MRI) including diffusion-weighted imaging (DWI). Angiographic studies including CTA and contrast-enhanced magnetic resonance angiography (MRA) were conducted. Cervical and intracranial segments of the carotid, vertebral and intracranial arteries were assessed to exclude underlying atherosclerotic disease or vasculopathy. Electrocardiography and transthoracic echocardiography were performed in both cases to exclude a cardioembolic source. Patients' demographics, clinical presentations, infarction distributions, initial stroke management, and associated comorbidities are summarized in Table 1 .
The initial diagnosis of the carotid web in both patients was established by CTA as a noncalcified, shelf-like, hypodense projection at the internal carotid artery (ICA) bulb prior to DSA confirmation, while the contrast-enhanced MRA revealed an irregular noncharacteristic proximal ICA stenosis.
Patient 1 presented with recurrent small-vessel lacunar infarcts confined to the left parietal lobe ( Figure 1 ) within a two-month interval, initially managed conservatively with medical therapy. Patient 2 presented emergently with an acute left middle cerebral artery (MCA) M1 occlusion and ischemic infarction involving lateral left basal ganglia and corona radiata ( Figure 2 ). Noncontrast computed tomography (CT) and emergent MRI studies also demonstrated findings of a chronic left insular cortex infarction. Additional history of two prior left hemispheric strokes with good recovery and reportedly negative workup at an outside hospital was obtained. CTA demonstrated a mid-left MCA M1 segment occlusion that was managed by emergent mechanical thrombectomy under conscious sedation.
The M1 segment was recanalized after two passes of the Solitaire FR stent retriever device (EV3, Plymouth, MN, USA) restoring near-complete distal reperfusion (Thrombolysis in Cerebral Ischemia (TICI) score ¼ 2b). The procedure was complicated by a non-flow-limiting iatrogenic dissection of the midcervical left ICA.
The decision to proceed with cervical stenting as management for these symptomatic carotid web lesions was discussed and approved by a multidisciplinary cerebrovascular staff. After patient consent, carotid stenting was performed under monitored anesthesia care. Both patients were heparinized with a maximum activated clotting time (ACT) of approximately 250 seconds. Carotid stenting was performed using a selfexpandable closed cell stent (Xact stent, both 8 mm Â 20 mm, Abbott Vascular). In Patient 1, the procedure was under distal cerebral protection with a filter protection device (Emboshield 7.2 mm, Abbott Vascular) and a post-stenting angioplasty dilatation balloon (Viatrac Plus, Abbott Vascular) was used. In Patient 2, the presence of a downstream ICA dissection prevented the safe deployment of the protection device and no post-stenting angioplasty was performed. In addition, the mid-cervical dissection in Patient 2 also had endovascular treatment with deployment of a self-expanding intracranial stent (Neuroform 4.5 mm Â 20 mm, Stryker Neurovascular) with poststenting angioplasty using Gateway over the wire 4 mm Â 15 mm angioplasty balloon at the time of the treatment of the carotid web because of a progressive dissection-related stenosis in the interval since the mechanical thrombectomy procedure. Control angiography was performed at the end of both procedures to confirm the integrity of the cervical and intracranial and cervical arteries. The carotid stenting procedures are summarized in Table 2 .
Patients were monitored in an intensive care unit for a period of 24 hours after the procedure. Aspirin 81 mg and clopidogrel 75 mg therapy was continued for three 
Discussion
Carotid web was first described and histologically proven as a fibromuscular hyperplasia by Connett and Lansche in 1965. 1 Following this observation, 50 additional carotid web cases [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] (25 cases in a single report 5 ) and two cases of vertebral artery web 14 were subsequently described. Histopathologic examinations of surgical specimens showed an abnormal intimal layer that was affected by fibrosis, [1] [2] [3] 5, 8, 9, 11, 16 hyperplasia, 5-7 folding 14, 15 or atherosclerosis. 15 The web can be defined angiographically as a shelf-or triangular-like projection with stagnation and turbulences of the blood flow distal to it, which explains the proposed embolic mechanism of the ischemic stroke in these cases. Six studies noted the presence of a thrombus attached to the diaphragm. [5] [6] [7] [8] [9] 11, 13, 15 Both patients from our study had recurrent ischemic infarcts confined to a single arterial territory downstream from the web including one case presenting with a thromboembolic MCA occlusion. The mean presenting age of stroke associated with a carotid web is 42 years, being equally prevalent in men and women. 13 Apart from a single report of ICA web near the level of the first two cervical vertebrae, 10 all other reported cases involved the carotid bulb or ICA origin. Carotid webs have previously been reported manifesting as a rare form of fibromuscular dysplasia (FMD) 2-11,14-16 based on the non-atheromatous and noninflammatory (NANI) renal artery stenosis classification. 18 Medial FMD of the carotid artery is rarely symptomatic and is often incidentally discovered during evaluation of dizziness, headache or a cervical bruit whereas carotid webs appear to confer a high risk of recurrent thromboembolic stroke despite aspirin therapy. 13 The difference between the clinical features, prognosis and management of carotid webs and medial FMD necessitates their distinction as two independent radiological entities. The definition of a web on CTA includes two descriptors: (1) an endoluminal shelf-like projection arising from the posterior/posterolateral wall of the ICA at the level of the carotid bifurcation in the neck best demonstrated on oblique sagittal reformats (as illustrated in Figures 1 and 2) ; and (2) a septum evident of axial section CTA. 19 In our study, CTA successfully identified the web while MRA failed to detect these lesions. Most of the carotid webs reported in the literature were initially diagnosed on conventional angiography. DSA remains the angiographic gold standard with superior spatial and temporal resolution demonstrating both the intraluminal filling defect and distal turbulent flow resulting in delayed contrast washout from the carotid bulb. Several authors have reported the high recurrence rate for ischemic stroke secondary to carotid webs, presumably due to turbulent hemodynamics. 2, 3, [5] [6] [7] [8] [9] [11] [12] [13] 16 Therefore, CTA findings suspicious for carotid webs with no significant atherosclerotic disease in a patient with recurrent ischemic stroke, confined to the same territory despite medical therapy, should be followed by DSA to confirm the diagnosis.
Carotid endarterectomy (CEA) is the standard management of carotid webs and most frequently reported interventional treatment in the literature. [1] [2] [3] [5] [6] [7] [8] [9] 11, 12, [14] [15] [16] The evaluation of medical management for carotid web is limited with anticoagulation reported as a therapeutic option in only two patients 11, 13 and a 30% recurrence rate reported in a group of 20 Afro-Caribbean patients treated with antiplatelet therapy for atypical FMD; 5 however, several patients in this study had overt thrombus at the site of the FMD, so such antiplatelet therapy wouldn't be expected to work. Carotid stenting has been reported for carotid web management in two cases with satisfactory clinical results. 13 To the best of the authors' knowledge there are no larger randomized series of carotid web patients testing the CEA or carotid artery stenting (CAS) versus medical management.
The multidisciplinary decisions in favor of CAS as definite management for the two patients were made based on the availability of CAS at our institution and to limit the periprocedural risks of CEA especially in Patient 2. Apart from ICA dissection during an earlier mechanical thrombectomy intervention in Patient 2, the carotid webs in our study were treated successfully with carotid stenting with no intra-or postprocedural complications. One of our cases is unique in describing stenting of a carotid web shortly after mechanical thrombectomy for an acute intracranial largevessel occlusion. Furthermore, follow-up neurological examinations and carotid Doppler ultrasound studies were normal for up to one year in Patient 1 and three months in Patient 2. The relative short-term follow-up of the cases may be considered as a limitation; in such cases long-term follow-up is needed to determine whether future in-stent stenosis is an issue.
Conclusion
Carotid artery webs may be an underestimated though rare cause of recurrent thromboembolic stroke in young and middle-aged adults despite antiplatelet therapy. CTA may assist in identification, but DSA remains the gold standard for diagnosis of a carotid web. Carotid stenting appears to be a viable alternative to open surgical management for secondary stroke prevention.
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